Burnie Academy
MariTide: a once-a-month obesity drug in trials

MariTide: a once-a-month obesity drug in trials

MariTide is an experimental weight-loss injection from Amgen that may work for a whole month per shot. It is still in trials, not approved, and not sold anywhere, including India.

13 Jul 2026 · Burnie Academy
maritide glp-1 obesity clinical-trials

Most weight-loss shots today are taken once a week. What if one shot lasted a whole month? That is the idea behind MariTide. It is a new obesity medicine being studied by a company called Amgen. The full science name is maridebart cafraglutide (say: ma-ri-DE-bart ca-fra-GLU-tide). The short brand name is MariTide. Here is the most important thing first: MariTide is EXPERIMENTAL. It is still in clinical trials. It is NOT approved by any drug regulator. It is NOT sold in India or anywhere else. You cannot buy it. Let us look at what the trials actually found.

CONTINUE READING FOR FREE

Unlock the complete article

Register with just your mobile number and OTP. No password and no payment.

Use this same phone number in the Burnie mobile app. Your profile, liked articles and favourites will stay synced.

Track your food the honest way

Burnie helps you see your estimated calorie deficit with familiar Indian foods — no fake precision, no guilt trips.

Get Burnie on the App Store

Sign in with the same mobile number you use for Academy. Android public availability is being expanded.